Answer
Yes, rare diabetic ketoacidosis, including life-threatening and fatal cases, has been reported with dapagliflozin, a component of Xigduo, sometimes with blood glucose only moderately raised, below 14 mmol/L (250 mg/dL), so suggestive symptoms require immediate assessment regardless of glucose level.
Sources for this answer
- Xigduo 5 mg/850 mg film-coated tabletsAstraZeneca UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 26Document updated
Sources checked